Biosimilar Insights
-
Process Analytical Technology In The ADC Bioconjugation Process
4/23/2025
Integrating Process Analytical Technology into validated GMP processes is complex and costly, which requires thorough validation of equipment and cleaning methods. Explore more about PAT's role in ADC production.
-
Streamline Your Cell Therapy Manufacturing
4/21/2025
Are you looking to streamline your cell therapy manufacturing? Discover a platform that can help you deliver advanced cell therapy with increased productivity, flexibility, and reduced batch failure risk.
-
Pioneers And Visionaries: Cell Line Development And AAV Gene Therapy
4/15/2025
Viral vector-based gene therapies offer hope for treating rare genetic disorders and complex conditions. Discover an advanced AAV producer cell line that is revolutionizing scalable, efficient, and accessible gene therapy production.
-
Transforming Life Science With Remote Equipment Monitoring
4/15/2025
Life science organizations are shifting to data-driven oversight. Discover how remote monitoring technologies are revolutionizing operational efficiency and innovation.
-
Optimizing TFF And SPTFF For High-Concentration mAb Formulations
4/9/2025
Discover the critical role of formulation buffer composition in stabilizing monoclonal antibodies during tangential flow filtration, a process involving ultrafiltration and diafiltration under high pressure and shear forces.
-
Selecting A Platform Filter For High Concentration mAbs
4/9/2025
Read more about how Fujifilm Diosynth Biotechnologies evaluated a prime filter with challenging simulant solutions and how the experimental data confirmed superior performance, which demonstrated twice the throughput.
-
Implementation Of Multi-Column Chromatography Systems
4/4/2025
Discover how a multi-column chromatography system enhances resin utility and enables continuous bioprocessing with minimal surge tankage for agile multi-product facilities.
-
Indian Biosimilar Companies Are Poised To Succeed In The Global Market
3/31/2025
For Indian biosimilar developers looking to capitalize on the upcoming patent cliff, it is vital to play to your strengths and identify strategies for breaking into competitive regulatory markets.
-
Advancing Cell Therapies With Lipid Nanoparticles
3/24/2025
Cell therapies, using reprogrammed immune cells, offer innovative treatments for diseases. Discover how lipid nanoparticles (LNPs) enhance these therapies by delivering RNA for gene modulation and next-gen treatments.
-
Replicate Bioscience And Cytiva Collaborate To Deliver srRNA-LNP Vaccines
3/24/2025
Discover how self-replicating RNA (srRNA) can revolutionize vaccine development with sustained protein expression, lower doses, and fewer side effects to advance next-gen RNA therapeutics.